Tender opportunity: Feasibility study for health and life sciences sector growth

By |2022-03-24T13:53:53+00:00March 24th, 2022|News|

The health and life science cluster in Newcastle is growing at pace, with demand far… Continue Reading Tender opportunity: Feasibility study for health and life sciences sector growth

Comments Off on Tender opportunity: Feasibility study for health and life sciences sector growth

Clifford Chance signs new building lease as Newcastle office primes for growth.

By |2022-03-24T13:14:21+00:00March 24th, 2022|News|

International law firm Clifford Chance has today signed a ten-year lease for 15,000 sq ft… Continue Reading Clifford Chance signs new building lease as Newcastle office primes for growth.

Comments Off on Clifford Chance signs new building lease as Newcastle office primes for growth.

Investment opportunity in Newcastle’s successful life sciences sector

By |2022-03-09T13:03:07+00:00March 9th, 2022|News|

Enquiries are now being welcomed from private sector investors interested in leading a project to… Continue Reading Investment opportunity in Newcastle’s successful life sciences sector

Comments Off on Investment opportunity in Newcastle’s successful life sciences sector

CellulaREvolution raises £1.75m to accelerate the launch of their Continuous Cell Culture Technology.

By |2022-02-18T14:33:56+00:00February 18th, 2022|News|

Biotech technology disrupter CellulaREvolution, which aims to revolutionise the way cells are grown, has… Continue Reading CellulaREvolution raises £1.75m to accelerate the launch of their Continuous Cell Culture Technology.

Comments Off on CellulaREvolution raises £1.75m to accelerate the launch of their Continuous Cell Culture Technology.

Iksuda Therapeutics deepens clinical pipeline through licensing agreement for Her2 antibody drug conjugate programme from LegoChem Biosciences.

By |2022-02-18T11:51:29+00:00January 10th, 2022|News|

Iksuda Therapeutics (Iksuda), the developer of a new generation of antibody drug conjugates (ADCs)… Continue Reading Iksuda Therapeutics deepens clinical pipeline through licensing agreement for Her2 antibody drug conjugate programme from LegoChem Biosciences.

Comments Off on Iksuda Therapeutics deepens clinical pipeline through licensing agreement for Her2 antibody drug conjugate programme from LegoChem Biosciences.

Life science talent specialist RBW Consulting set to expand its thriving operation with new North East office

By |2022-01-06T10:42:07+00:00January 6th, 2022|News|

Life sciences talent and strategic consultancy, RBW Consulting, has today announced the opening of… Continue Reading Life science talent specialist RBW Consulting set to expand its thriving operation with new North East office

Comments Off on Life science talent specialist RBW Consulting set to expand its thriving operation with new North East office

Biotech company developing nanorobots to improve cancer diagnosis joins Newcastle Helix

By |2021-09-29T08:09:11+00:00September 29th, 2021|News|

A Newcastle biotech, specialising in nanorobotic technology to improve the diagnosis of some of… Continue Reading Biotech company developing nanorobots to improve cancer diagnosis joins Newcastle Helix

Comments Off on Biotech company developing nanorobots to improve cancer diagnosis joins Newcastle Helix
Go to Top